Key combination for the treatment of Small Cell Lung Cancer MADRID and CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...
CdM | Oryzon Genomics has announced that the Mexican Patent Office has issued a decision to grant patent application MX/a/2021/011610, entitled ‘Combinations ...
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results